The article discusses the white paper released by Leavitt Partners on April 17, 2018 that urge mental health services providers to implement a measurement-based system where validated symptom rating scales for patient with major depressive disorder (MDD) are performed during visits. It notes that MDD is a serious comorbidity with numerous other medical conditions including hypertension, coronary artery disease and diabetes.